Dolcera releases new Patent Dashboard v1.1

Dolcera Corporation, a leading information services and technology firm that helps companies quickly and effectively navigate through their entire innovation cycle to achieve successful business outcomes, today announced its new Patent Dashboard, available for the first time as a standalone platform.

Dolcera's flagship software as a service (SaaS) Patent Dashboard is a proprietary Web 2.0-based collaborative tool that enables companies to visualize, search, and map the relevant competitive patent landscape, determine patent value, and ultimately accelerate the time to commercialize their patents. The new Patent Dashboard v1.1 provides greater flexibility and control as well as enhanced search and reporting capabilities.

Mapping the Patent Landscape

Today, patents are under greater scrutiny, take longer to be approved, and can cost several hundred thousands of dollars from application until grant stage. At the same time, patents represent new sources of revenue through commercialization or acquisition, and are also viewed as points of differentiation and competitive advantage.

The Patent Dashboard's ease of use and flexibility, along with its collaboration capabilities, make it easy and practical for experts and non-experts to use. It may also be used alone or with other patent tools, such as those for search, intellectual asset management, or research.

Among the new features of the Dolcera Patent Dashboard Tool v1.1 are:

  • Custom Taxonomies and Patent Additions by users on the fly, based on their topics of interest;
  • Editable Patent Categories that can be easily moved within the Dashboard;
  • Enhanced Researching and Reporting, with patent searches (even complex Boolean ones) and information filters; and
  • Enhanced Collaboration via relevance rankings, referral tagging, track changes, and data security for selective user access.

The Dolcera Patent Dashboard is sold directly; a single full and functional user license starts from $49 per user per month.

Source Dolcera

www.dolcera.com  

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics